Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease
NCT06643013
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
106
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Small Vessel Disease
Interventions
DRUG:
XBD173
Sponsor
Imperial College London